Literature DB >> 1576051

The effect of ageing on plasma albumin and plasma protein binding of diazepam, salicylic acid and digitoxin in healthy subjects and patients with renal impairment.

A Viani1, G Rizzo, M Carrai, G M Pacifici.   

Abstract

1. Plasma albumin concentration was measured in 118 healthy subjects (aged between 18 and 87 years), in 95 renal patients with creatinine clearances between 15 and 50 ml min-1 (aged between 14 and 79 years) and in 101 uraemic patients maintained on chronic haemodialysis (aged between 27 and 83 years). 2. There was a significant (P less than 0.001) negative correlation between albumin concentration and age in healthy subjects, but no correlation in patients with low creatinine clearance or in uraemic patients. 3. The ex vivo plasma binding of diazepam (1 microM), salicylic acid (2 mM) and digitoxin (37 nM) was studied in groups of age-selected young and aged healthy subjects in patients with low creatinine clearance and in patients with uraemia. The unbound fractions of diazepam and salicylic acid were about double in old compared with young healthy subjects whereas they were similar in young and old patients with lowered creatinine clearance. In uraemic patients, ageing did not affect the binding of salicylic acid whereas the unbound fraction of diazepam was slightly but significantly greater in elderly subjects. The unbound fraction of digitoxin was independent of age in both healthy subjects and in those with renal disease. 4. Decreased plasma binding of diazepam and salicylic acid was partially corrected by extensive dialysis of plasma. The lower plasma binding of diazepam and salicylic acid associated with ageing may be ascribed to the effects of endogenous displacers and to hypoalbuminaemia. The influence of these two factors appears to be drug-dependent.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1576051      PMCID: PMC1381279          DOI: 10.1111/j.1365-2125.1992.tb04039.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  23 in total

1.  Interaction of 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, an inhibitor of plasma protein binding in uraemia, with human albumin.

Authors:  S J Henderson; W E Lindup
Journal:  Biochem Pharmacol       Date:  1990-12-01       Impact factor: 5.858

2.  The effect of age on serum concentrations of albumin and alpha 1-acid glycoprotein.

Authors:  B T Veering; A G Burm; J H Souverijn; J M Serree; J Spierdijk
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335

Review 3.  Pharmacokinetics of salicylate in man.

Authors:  G Levy
Journal:  Drug Metab Rev       Date:  1979       Impact factor: 4.518

Review 4.  Plasma protein binding of drugs in the elderly.

Authors:  S M Wallace; R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

5.  Direct and indirect determination of binding constants of drug-protein complexes with microparticles.

Authors:  A Kober; B Ekman; I Sjöholm
Journal:  J Pharm Sci       Date:  1978-01       Impact factor: 3.534

6.  Bilirubin displaces furosemide from serum protein: the effect is greater in newborn infants than adult subjects.

Authors:  A Viani; G M Pacifici
Journal:  Dev Pharmacol Ther       Date:  1989

7.  Serum protein binding of phenytoin, diazepam and propranolol in chronic renal diseases.

Authors:  E Tiula; L G Tallgren; P J Neuvonen
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1987-10

8.  Plasma protein binding of dicloxacillin: effects of age and diseases.

Authors:  G M Pacifici; A Viani; G Taddeucci-Brunelli; G Rizzo; M Carrai
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1987-11

9.  The effects of age and smoking on the plasma protein binding of lignocaine and diazepam.

Authors:  D Davis; S H Grossman; B B Kitchell; D G Shand; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335

10.  Acetaldehyde adducts with serum proteins: effect on diazepam and phenytoin binding.

Authors:  D Lucas; J F Ménez; J Y Daniel; L G Bardou; H H Floch
Journal:  Pharmacology       Date:  1986       Impact factor: 2.547

View more
  7 in total

Review 1.  Age-related changes in protein binding of drugs: implications for therapy.

Authors:  M K Grandison; F D Boudinot
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

Review 2.  Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.

Authors:  G M Pacifici; A Viani
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

Review 3.  The role of the protein-binding on the mode of drug action as well the interactions with other drugs.

Authors:  Christine Tesseromatis; Anastasia Alevizou
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Oct-Dec       Impact factor: 2.441

4.  International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.

Authors:  Margarita L Dubocovich; Philippe Delagrange; Diana N Krause; David Sugden; Daniel P Cardinali; James Olcese
Journal:  Pharmacol Rev       Date:  2010-07-06       Impact factor: 25.468

5.  Changes of lidocaine levels in rat serum and tissue under stress and hyperlipidaemic diets.

Authors:  Dimitrios Karakitsos; Andreas Karabinis; Antonia Kotsiou
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2009 Jul-Sep       Impact factor: 2.441

6.  Characteristics of plasma protein binding of tacrine hydrochloride: a new drug for Alzheimer's disease.

Authors:  P M Mäkelä; C A Truman; J M Ford; C J Roberts
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

7.  Anticoagulant-induced changes on antibiotic concentrations in the serum and bones.

Authors:  A Kotsiou; E Diamanti; A Potamianou; H Parara; J Vovou; C Perisanidis; C Tes; C Tesseromatis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Jul-Sep       Impact factor: 2.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.